We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$194M
AUM Growth
+$9.69M
Cap. Flow
+$1.08M
Cap. Flow %
0.56%
Top 10 Hldgs %
37.36%
Holding
111
New
7
Increased
29
Reduced
23
Closed
5

Top Buys

Rank Stock Value
1
BWA icon
BorgWarner
BWA
+$2.31M
2
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
+$1.31M
3
APA icon
APA Corp
APA
+$793K
4
BA icon
Boeing
BA
+$454K
5
ICE icon
Intercontinental Exchange
ICE
+$342K

Top Sells

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$2.09M
2
PRU icon
Prudential Financial
PRU
+$1.21M
3
MRNA icon
Moderna
MRNA
+$390K
4
LDOS icon
Leidos
LDOS
+$347K
5
DE icon
Deere & Co
DE
+$192K

Sector Composition

Rank Sector Weight
1 Technology 21.81%
2 Industrials 17.11%
3 Healthcare 16.97%
4 Financials 14.32%
5 Consumer Discretionary 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
26
Amgen
AMGN
$203B
$2.66M 1.37%
9,356
-70
-0.7% -$20.5K
MS icon
27
Morgan Stanley
MS
$337B
$2.56M 1.32%
27,218
+3
+0% +$264
V icon
28
Visa
V
$677B
$2.51M 1.3%
9,003
-25
-0.3% -$6.9K
BWA icon
29
BorgWarner
BWA
$13.2B
$2.46M 1.27%
+70,745
New +$2.31M
VGR
30
DELISTED
Vector Group Ltd.
VGR
$2.43M 1.25%
221,830
+800
+0.4% +$8.69K
CVS icon
31
CVS Health
CVS
$137B
$2.25M 1.16%
28,265
+250
+0.9% +$19.1K
LMT icon
32
Lockheed Martin
LMT
$134B
$2.21M 1.14%
4,855
– –
CI icon
33
Cigna
CI
$76.6B
$2.2M 1.13%
6,061
+1
+0% +$329
VRTX icon
34
Vertex Pharmaceuticals
VRTX
$121B
$2.15M 1.11%
5,135
– –
BAM icon
35
Brookfield Asset Management
BAM
$74B
$2.13M 1.1%
50,623
– –
AMZN icon
36
Amazon
AMZN
$2.5T
$1.92M 0.99%
10,645
+20
+0.2% +$3.34K
QCOM icon
37
Qualcomm
QCOM
$176B
$1.91M 0.98%
11,257
-239
-2% -$36.9K
J icon
38
Jacobs Solutions
J
$15.9B
$1.9M 0.98%
14,942
– –
TRP icon
39
TC Energy
TRP
$73.5B
$1.77M 0.91%
44,117
– –
MRK icon
40
Merck
MRK
$324B
$1.57M 0.81%
11,927
+102
+0.9% +$12.6K
STZ icon
41
Constellation Brands
STZ
$22.2B
$1.47M 0.76%
5,408
-25
-0.5% -$6.33K
COO icon
42
Cooper Companies
COO
$13.7B
$1.36M 0.7%
13,440
– –
LSXMA
43
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$1.29M 0.67%
+43,450
New +$1.31M
META icon
44
Meta Platforms (Facebook)
META
$1.51T
$1.26M 0.65%
2,595
-55
-2% -$24.5K
JNJ icon
45
Johnson & Johnson
JNJ
$635B
$1.24M 0.64%
7,842
– –
ORCL icon
46
Oracle
ORCL
$331B
$1.14M 0.59%
9,081
– –
MDT icon
47
Medtronic
MDT
$107B
$1.14M 0.59%
13,060
+200
+2% +$17.1K
MRNA icon
48
Moderna
MRNA
$21.5B
$1.12M 0.58%
10,497
-3,865
-27% -$390K
CARR icon
49
Carrier Global
CARR
$57.2B
$1.11M 0.57%
19,180
+2
+0% +$112
HSY icon
50
Hershey
HSY
$35.4B
$1.09M 0.56%
5,590
+2
+0% +$386
1
2
3 4 5

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Lipe & Dalton's Q1 2024 Portfolio in Review

As of Q1 2024, Lipe & Dalton held 111 positions worth $194M, up 5.3% from $184M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Lipe & Dalton's Q1 2024 filing shows 7 new, 29 increased, 23 reduced and 5 closed positions. Its largest new stake was BorgWarner: 70,745 shares worth $2.46M. The largest sale was Synchrony, an estimated $2.09M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Lipe & Dalton's largest Q1 2024 buy was BorgWarner: 70,745 shares worth $2.46M.
  • Lipe & Dalton added most to Boeing in Q1 2024, an estimated $454K increase.
  • Lipe & Dalton's biggest Q1 2024 reduction was Moderna, cutting an estimated $390K.
  • Lipe & Dalton fully exited Synchrony in Q1 2024, selling an estimated $2.09M.
  • Lipe & Dalton's ten largest holdings make up 37% of its $194M portfolio in Q1 2024.
  • Lipe & Dalton opened 7 new positions and closed 5 in Q1 2024.
  • Lipe & Dalton's portfolio value rose 5.3% quarter-over-quarter to $194M.

Based on Lipe & Dalton's 13F filing for Q1 2024, filed 7 May 2024.